Primary tabs
The list of publications is indicative and may not include all publications.
Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease..
Acta Gastroenterol Belg. 85(2), 331-337.
(2022).
Enhanced recovery after surgery in liver transplantation: Challenges and feasibility..
World J Transplant. 12(7), 195-203.
(2022).
Effects of an active lifestyle on the physical frailty of liver transplant candidates..
World J Transplant. 12(11), 365-377.
(2022).
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?.
Ann Hepatol. 19(2), 134-144.
(2020).
'Distribution of Hepatitis C Virus genotypes in northern Greece in the last decade: descriptive analysis and clinical correlations'..
Glob Health Epidemiol Genom. 4, e5.
(2019).
The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis..
Eur J Gastroenterol Hepatol. 31(7), 897-898.
(2019).
Prevalence of hepatitis E in liver transplant recipients in Greece..
Epidemiol Infect. 146(13), 1619-1621.
(2018).
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?.
World J Hepatol. 10(11), 790-794.
(2018).
Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre..
Br J Haematol. 181(1), 140-142.
(2018).
Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature..
Clin Mol Hepatol. 24(3), 345-349.
(2018).
Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017).
Anticholinergic syndrome induced by toxic plants..
World J Emerg Med. 8(4), 297-301.
(2017).
Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis..
J Gastroenterol Hepatol. 32(1), 191-198.
(2017).
Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population..
Pharmacol Rep. 68(2), 476-82.
(2016).
Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels..
Ann Gastroenterol. 29(2), 208-13.
(2016).
Treatment of alcoholic hepatitis: is this a "dead-end"?.
Ann Gastroenterol. 29(2), 236-7.
(2016).
Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience..
Ann Gastroenterol. 28(4), 481-6.
(2015).
Value of 3 Tesla diffusion-weighted magnetic resonance imaging for assessing liver fibrosis..
Ann Gastroenterol. 28(1), 118-123.
(2015).
Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients..
Ann Gastroenterol. 28(3), 374-378.
(2015).
Focal nodular hyperplasia in an individual with Abernethy malformation type 1b..
Dig Liver Dis. 47(12), 1089.
(2015).
Authors' reply..
Ann Gastroenterol. 28(4), 507.
(2015).
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis..
World J Hepatol. 6(4), 178-87.
(2014).